Multiple system atrophy
(Redirected from Shy-Drager Syndrome)
Multiple System Atrophy (MSA) is a rare, progressive neurodegenerative disorder characterized by a combination of symptoms affecting movement, balance, and the autonomic nervous system. Although its etiology remains unclear, a significant hallmark of MSA is the presence of a misfolded form of the alpha-synuclein protein within neurons.
Clinical Presentation[edit | edit source]
Patients with MSA often present with a combination of parkinsonian symptoms, such as tremors, bradykinesia (slow movement), rigidity, and postural instability, as well as cerebellar symptoms including ataxia (impaired coordination of movement). Unlike Parkinson's Disease, however, these symptoms are usually poorly responsive to dopaminergic therapy, which can aid in differential diagnosis.
One of the defining characteristics of MSA is autonomic dysfunction, which can manifest as:
Orthostatic hypotension (a decrease in blood pressure upon standing) Impotence Altered sweating patterns Xerostomia (dry mouth) Urinary retention and incontinence Voice changes due to vocal cord palsy can also be an early sign of the disorder.
Pathophysiology[edit | edit source]
Neurodegeneration in MSA affects multiple parts of the brain, including the basal ganglia, inferior olivary nucleus, and cerebellum. The precise cause of this neuronal loss is not well understood, but it is associated with the presence of abnormal, misfolded alpha-synuclein protein within neuronal cells, leading to cell damage and death.
Epidemiology[edit | edit source]
MSA typically appears in individuals between the ages of 50-60, with a slightly higher prevalence in men, accounting for approximately 55% of cases.
Differential Diagnosis[edit | edit source]
While MSA shares some symptoms with Parkinson's Disease, the lack of response to dopaminergic medications, among other differences, helps distinguish the two conditions. MSA should also not be confused with multisystem proteinopathy, a more common muscle wasting syndrome, or with multiple organ dysfunction syndrome/multiple organ system failure, which are severe complications often associated with septic shock or other severe illnesses.
References[edit | edit source]
See Also[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
WikiMD is not a substitute for professional medical advice. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD